Cargando…

Safer opioid supply via a biometric dispensing machine: a qualitative study of barriers, facilitators and associated outcomes

BACKGROUND: The MySafe program provides pharmaceutical-grade opioids to participants with opioid use disorder via a biometric dispensing machine. The objectives of this study were to examine facilitators and barriers to safer supply via the MySafe program and the associated outcomes. METHODS: We con...

Descripción completa

Detalles Bibliográficos
Autores principales: Bardwell, Geoff, Ivsins, Andrew, Mansoor, Manal, Nolan, Seonaid, Kerr, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CMA Impact Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185363/
https://www.ncbi.nlm.nih.gov/pubmed/37188370
http://dx.doi.org/10.1503/cmaj.221550
_version_ 1785042340037001216
author Bardwell, Geoff
Ivsins, Andrew
Mansoor, Manal
Nolan, Seonaid
Kerr, Thomas
author_facet Bardwell, Geoff
Ivsins, Andrew
Mansoor, Manal
Nolan, Seonaid
Kerr, Thomas
author_sort Bardwell, Geoff
collection PubMed
description BACKGROUND: The MySafe program provides pharmaceutical-grade opioids to participants with opioid use disorder via a biometric dispensing machine. The objectives of this study were to examine facilitators and barriers to safer supply via the MySafe program and the associated outcomes. METHODS: We conducted semistructured interviews with participants who had been enrolled in the MySafe program for at least a month at 1 of 3 sites in Vancouver. We developed the interview guide in consultation with a community advisory board. Interviews focused on context of substance use and overdose risk, enrolment motivations, program access and functionality, and outcomes. We integrated case study and grounded theory methodologies, and used both conventional and directed content analyses to guide inductive and deductive coding processes. RESULTS: We interviewed 46 participants. Characteristics that facilitated use of the program included accessibility and choice, a lack of consequences for missing doses, nonwitnessed dosing, judgment-free services and an ability to accumulate doses. Barriers included technological issues with the dispensing machine, dosing challenges and prescriptions being tied to individual machines. Participant-reported outcomes included reduced use of illicit drugs, decreased overdose risk, positive financial impacts and improvements in health and well-being. INTERPRETATION: Participants perceived that the MySafe program reduced drug-related harms and promoted positive outcomes. This service delivery model may be able to circumvent barriers that exist at other safer opioid supply programs and may enable access to safer supply in settings where programs may otherwise be limited.
format Online
Article
Text
id pubmed-10185363
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher CMA Impact Inc.
record_format MEDLINE/PubMed
spelling pubmed-101853632023-05-16 Safer opioid supply via a biometric dispensing machine: a qualitative study of barriers, facilitators and associated outcomes Bardwell, Geoff Ivsins, Andrew Mansoor, Manal Nolan, Seonaid Kerr, Thomas CMAJ Research BACKGROUND: The MySafe program provides pharmaceutical-grade opioids to participants with opioid use disorder via a biometric dispensing machine. The objectives of this study were to examine facilitators and barriers to safer supply via the MySafe program and the associated outcomes. METHODS: We conducted semistructured interviews with participants who had been enrolled in the MySafe program for at least a month at 1 of 3 sites in Vancouver. We developed the interview guide in consultation with a community advisory board. Interviews focused on context of substance use and overdose risk, enrolment motivations, program access and functionality, and outcomes. We integrated case study and grounded theory methodologies, and used both conventional and directed content analyses to guide inductive and deductive coding processes. RESULTS: We interviewed 46 participants. Characteristics that facilitated use of the program included accessibility and choice, a lack of consequences for missing doses, nonwitnessed dosing, judgment-free services and an ability to accumulate doses. Barriers included technological issues with the dispensing machine, dosing challenges and prescriptions being tied to individual machines. Participant-reported outcomes included reduced use of illicit drugs, decreased overdose risk, positive financial impacts and improvements in health and well-being. INTERPRETATION: Participants perceived that the MySafe program reduced drug-related harms and promoted positive outcomes. This service delivery model may be able to circumvent barriers that exist at other safer opioid supply programs and may enable access to safer supply in settings where programs may otherwise be limited. CMA Impact Inc. 2023-05-15 2023-05-15 /pmc/articles/PMC10185363/ /pubmed/37188370 http://dx.doi.org/10.1503/cmaj.221550 Text en © 2023 CMA Impact Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Research
Bardwell, Geoff
Ivsins, Andrew
Mansoor, Manal
Nolan, Seonaid
Kerr, Thomas
Safer opioid supply via a biometric dispensing machine: a qualitative study of barriers, facilitators and associated outcomes
title Safer opioid supply via a biometric dispensing machine: a qualitative study of barriers, facilitators and associated outcomes
title_full Safer opioid supply via a biometric dispensing machine: a qualitative study of barriers, facilitators and associated outcomes
title_fullStr Safer opioid supply via a biometric dispensing machine: a qualitative study of barriers, facilitators and associated outcomes
title_full_unstemmed Safer opioid supply via a biometric dispensing machine: a qualitative study of barriers, facilitators and associated outcomes
title_short Safer opioid supply via a biometric dispensing machine: a qualitative study of barriers, facilitators and associated outcomes
title_sort safer opioid supply via a biometric dispensing machine: a qualitative study of barriers, facilitators and associated outcomes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185363/
https://www.ncbi.nlm.nih.gov/pubmed/37188370
http://dx.doi.org/10.1503/cmaj.221550
work_keys_str_mv AT bardwellgeoff saferopioidsupplyviaabiometricdispensingmachineaqualitativestudyofbarriersfacilitatorsandassociatedoutcomes
AT ivsinsandrew saferopioidsupplyviaabiometricdispensingmachineaqualitativestudyofbarriersfacilitatorsandassociatedoutcomes
AT mansoormanal saferopioidsupplyviaabiometricdispensingmachineaqualitativestudyofbarriersfacilitatorsandassociatedoutcomes
AT nolanseonaid saferopioidsupplyviaabiometricdispensingmachineaqualitativestudyofbarriersfacilitatorsandassociatedoutcomes
AT kerrthomas saferopioidsupplyviaabiometricdispensingmachineaqualitativestudyofbarriersfacilitatorsandassociatedoutcomes